Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
8 participants
INTERVENTIONAL
2004-08-28
2008-05-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms
NCT00180401
MODULA Modul 5 BEAT-HF
NCT00273091
Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post Marketing Study
NCT00246805
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
NCT00267098
VERRARI - "Are Ventricular Arrhythmic Episodes Reduced by Rate Response in ICDs?"
NCT00180427
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ventricular Rate Regulation feature ON
CRT devices with ventricular rate regulation [VRR] (CE labeled)
Ventricular Rate Regulation feature OFF
CRT devices with ventricular rate regulation [VRR] (CE labeled)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CRT devices with ventricular rate regulation [VRR] (CE labeled)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with permanent atrial fibrillation
* Occasional conducted atrial fibrillation resulting in ventricular rates \> 70 beats per minute (bpm)
* QRS complex \> 120 ms
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guidant Corporation
INDUSTRY
Boston Scientific Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bernd Lemke, MD
Role: PRINCIPAL_INVESTIGATOR
Klinikum Lüdenscheid / Kardiologie / Paulmannshöher Straße 14 / 58515 Lüdenscheid / Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinikum Lüdenscheid / Kardiologie
Lüdenscheid, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Version vom 10.07.2003 BIS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.